These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3915040)

  • 1. Analysis of the immunological mechanisms in the F1 hybrid anti-parental reactivity, and detection of a new minor histocompatibility 42(H-42) locus by F1 cytotoxic T lymphocytes generated under the condition of graft-versus-host reaction.
    Ishikawa H
    Keio J Med; 1985 Dec; 34(4):199-210. PubMed ID: 3915040
    [No Abstract]   [Full Text] [Related]  

  • 2. Modulation of F1 cytotoxic potentials by GvHR: role and mode of action of non-MHC genes that determine the hybrid resistance to GvHR-associated suppression of F1 cytotoxic potential.
    Ishikawa H; Kubota E; Saito K
    J Immunol; 1984 May; 132(5):2218-25. PubMed ID: 6232314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The target minor H antigen for F1 cytotoxic T lymphocytes induced by Igh-congenic parental spleen cells is coded for by gene linked to H-2.
    Ishikawa H; Kubota E; Suzuki H; Saito K
    J Immunol; 1985 May; 134(5):2953-9. PubMed ID: 2580009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of F1 cytotoxic potentials by GvHR. Host- and donor-derived cytotoxic lymphocytes arise in the unirradiated F1 host spleens under the condition of GvHR-associated immunosuppression.
    Kubota E; Ishikawa H; Saito K
    J Immunol; 1983 Sep; 131(3):1142-8. PubMed ID: 6604089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. H-41, a new minor histocompatibility locus. I. Histogenetic analysis.
    Juretić A; Vucak I; Malenica B; Nagy ZA; Klein J
    J Immunol; 1984 Dec; 133(6):2950-4. PubMed ID: 6386980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of F1 hybrid resistance to bone marrow grafts after injection of parental lymphocytes. Demonstration of parental anti-F1 T killer cells and general immunosuppression in the host.
    Knobloch C; Dennert G
    Transplantation; 1988 Jan; 45(1):175-83. PubMed ID: 3276048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of correlation between cytolytic T lymphocytes and lethal murine graft-versus-host disease in response to minor histocompatibility antigens.
    Hamilton BL
    Transplantation; 1984 Oct; 38(4):357-60. PubMed ID: 6388062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo priming of mouse CTL precursors directed to product of a newly defined minor H-42 locus is under a novel control of class II MHC gene.
    Ishikawa H; Suzuki H; Hino T; Kubota E; Saito K
    J Immunol; 1985 Dec; 135(6):3681-5. PubMed ID: 3934264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of correlation between graft-versus-host associated immunosuppression and cytotoxic T cell activity in response to major histocompatibility antigens.
    Lang P; Bierre V; Baron C; Cholin S; Rostoker G; Weil B
    Transpl Int; 1992; 5 Suppl 1():S681-3. PubMed ID: 14621909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative abilities of parental thymus and spleen cells to induce graft-versus-host reactions and enhance antibody formation in F1 hybrid mice.
    Lindholm L; Strannegård O
    Int Arch Allergy Appl Immunol; 1974; 47(4):520-31. PubMed ID: 4153468
    [No Abstract]   [Full Text] [Related]  

  • 11. Differential resistance to growth of a tumor expressing incompatible minor alloantigens reflects regulatory influences rather than differences in anti-minor-CTL-P frequencies.
    Carayanniotis G; Halloran PF
    Cell Immunol; 1985 Mar; 91(1):100-10. PubMed ID: 2857596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A class II antigen-specific T cell clone can suppress graft-versus-host reactivity in murine allogeneic bone marrow chimeras.
    Shih CC; Truitt RL
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2664-7. PubMed ID: 2950639
    [No Abstract]   [Full Text] [Related]  

  • 13. Split tolerance in chimeric GVH mice.
    Baron C; Lang P; Bierre V; Rostoker G; Weil B
    Transpl Int; 1994; 7 Suppl 1():S606-10. PubMed ID: 11271320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H-2-restriction of T cells mediating lethal graft-versus-host-disease to minor histocompatibility determinants.
    Sprent J; Korngold R
    Adv Exp Med Biol; 1982; 149():531-6. PubMed ID: 6816025
    [No Abstract]   [Full Text] [Related]  

  • 15. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
    Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
    J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. F1 hybrid resistance and self-tolerance in graft-versus-host mice.
    Baron C; Bierre V; Weil B; Lang P
    Transplant Proc; 1996 Oct; 28(5):2921-2. PubMed ID: 8908125
    [No Abstract]   [Full Text] [Related]  

  • 17. Abrogation of hybrid resistance to bone marrow engraftment by graft-vs-host-induced immune deficiency.
    Hakim FT; Shearer GM
    J Immunol; 1986 Nov; 137(10):3109-16. PubMed ID: 3095424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural resistance to parental T-lymphocyte-induced immunosuppression in F1 hybrid mice: implications for acquired immune deficiency syndrome (AIDS).
    Shearer GM
    Immunol Rev; 1983; 73():115-26. PubMed ID: 6350157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of major and minor histocompatibility antigens in the graft-versus-host reaction.
    Pritchard LL; Halle-Pannenko O
    Transplantation; 1981 Apr; 31(4):257-61. PubMed ID: 7013172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-receptor anti-MHC cytotoxic T lymphocytes: their role in the resistance to graft vs host reaction.
    Kosmatopoulos K; Algara DS; Orbach-Arbouys S
    J Immunol; 1987 Feb; 138(4):1038-41. PubMed ID: 3492538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.